ProPhase Labs
PRPH
PRPH was delisted on the 2nd of January, 2026.
33 hedge funds and large institutions have $1.05M invested in ProPhase Labs in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 12 closing their positions.
500% more call options, than puts
Call options by funds: $6K | Put options by funds: $1K
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
1.03% less ownership
Funds ownership: 1.67% → 0.64% (-1%)
11% less funds holding
Funds holding: 37 → 33 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
48% less capital invested
Capital invested by funds: $2.02M → $1.05M (-$970K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sykon Capital
Harrison,
New York
|
+$216K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$34.3K |
| 3 |
Citigroup
New York
|
+$19.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.2K |
| 5 |
VF
Virtu Financial
New York
|
+$13.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$617K |
| 2 |
FCM
FourWorld Capital Management
New York
|
-$152K |
| 3 |
CFG
Citizens Financial Group
Providence,
Rhode Island
|
-$109K |
| 4 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$100K |
| 5 |
SSWM
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
-$84.2K |
PRPH Hedge Fund Activity: Q2 2025 in Review
33 of the 7,611 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q2 2025, worth a combined $1.05M — down 48% from $2.02M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PRPH and 8 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Sykon Capital, opening a new position worth an estimated $216K. The largest seller was Wexford Capital, exiting entirely with an estimated $617K sold.
- 33 institutional investors held ProPhase Labs (PRPH) as of Q2 2025, down from 37 in Q1 2025.
- Funds reported $1.05M of ProPhase Labs stock for Q2 2025, down 48% quarter-over-quarter.
- 8 funds opened new ProPhase Labs positions in Q2 2025 and 12 closed out, a net change of -4 holders.
- The largest ProPhase Labs buyer in Q2 2025 was Sykon Capital, an estimated $216K added.
- The largest ProPhase Labs seller in Q2 2025 was Wexford Capital, an estimated $617K sold.
Based on aggregated 13F filings for Q2 2025.